A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508

Standard treatment for clinical stage I esophageal cancer with submucosal invasion (T1b) has been surgical resection. We conducted a Phase II trial to evaluate the efficacy and the safety of combined treatment of endoscopic mucosal resection (EMR) and chemoradiotherapy for clinical stage I (T1b) eso...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurokawa, Yukinori, Muto, Manabu, Minashi, Keiko, Boku, Narikazu, Fukuda, Haruhiko
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2009
Materias:
Clinical Trial Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755303/
https://www.ncbi.nlm.nih.gov/pubmed/19703839
http://dx.doi.org/10.1093/jjco/hyp078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755303/
https://www.ncbi.nlm.nih.gov/pubmed/19703839
http://dx.doi.org/10.1093/jjco/hyp078

Ejemplares similares